Frontlight ResearchEarly access
Mitochondrial disease trials in Netherlands
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleKHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
- Where
- Nijmegen
- Age
- 18 years to 64 years
- People
- 220 worldwide
- Run by
- Khondrion BV
See details and how to joinNCT06451757 · EU 2025-522361-30-00 - Phase 2Not yet taking people in NetherlandsOpen Label Extension to Assess Long Term Safety and Efficacy of KL1333 in Patients With Primary Mitochondrial Disease
- Where
- Nijmegen
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Pharming Technologies B.V.
See details and how to joinNCT07514338 · EU 2025-524367-20-00 - No phaseNot yet taking people in NetherlandsProspective Natural History Study of POLG Disease
- Where
- Maastricht
- People
- 300 worldwide
- Run by
- The POLG Foundation
See details and how to joinNCT07775872 - Phase 2Taking peopleEfficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
- Where
- Nijmegen
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Pharming Technologies B.V.
See details and how to joinNCT05650229 · EU 2023-508624-35-00 - Phase 1/2Taking peopleAssess effect and safety of intra-arterial autologous mesoangioblast administration to the upper arm of m.3243A>G mutation carriers
- Where
- Maastricht
- Age
- 18 years to 64 years
- People
- 20
- Run by
- Academisch Ziekenhuis Maastricht
See details and how to joinNCT05962333 · EU 2024-515129-27-00